JerryBagelMDMS

Dermatology • East Windsor, NJ

Director:Psoriasis Treatment Center of Central New Jersey

Join to view full profile

Dr. Bagel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bagel's full profile

Already have an account?

Office
59 One Mile Rd
Ste G
East Windsor, NJ 08520
Phone+1 609-443-4500

Fax+1 609-443-4808

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Dermatology, 1982 - 1985
University of Miami/Jackson Health SystemInternship, Internal Medicine, 1981 - 1982
Icahn School of Medicine at Mount SinaiClass of 1981
Rutgers UniversityM.S., Biochemistry, 1977
Boston UniversityB.A., Biology, Cum Laude, 1975

Certifications & Licensure

NJ State Medical License 1984 - 2025
FL State Medical License 1982 - 1987
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

MCMS Award For Research And Patient Outreach Mercer County Medical Society, 2016
NPF Physician-Clinician of the Year Award National Psoriasis Foundation, 2016
AAD Presidential Citation For Excellence In Psoriasis Research American Academy of Dermatology, 2016
Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
Inside Jersey: Top Cosmetic Doctors Castle Connolly, 2011
NJ.com Top Doctors Castle Connolly, 2009
Inside Jersey: Top Doctor 2009-2011
Patients' Choice Award 2008
Volunteer of the Year National Psoriasis Foundation, 2007
President's Council Leader National Psoriasis Foundation, 2006
New Jersey Life: Top Doctors Castle Connolly, 2005
Doctor of the Year New Jersey Life, 2005
New York Metro Area: Top Doctor 2004-2008, 2012-2013
New Jersey Monthly: Top Doctors Castle Connolly, 2001, 2003
Golden Triangle Award 2002
Doctor of the Year New Jersey Magazine, 2001, 2003
Robert Wood Johnson Distinguished Volunteer Faculty Award 1997
Fellow (FAAD) American Academy of Dermatology
Join now to see all

Clinical Trials

Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy Start of enrollment: 2007 Jun 01
Completed
Not Applicable
NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study Start of enrollment: 2007 Apr 01
Completed
Not Applicable
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01
Completed
Phase 3
An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life Start of enrollment: 2013 Jul 01
Completed
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Completed
Phase 3
A Single-Center, Prospective, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy Start of enrollment: 2007 Mar 01
Completed
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3
Enstilar in Combination With Biologic Agents Start of enrollment: 2017 May 01
Completed
Phase 4
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients Start of enrollment: 2017 Nov 07
Recruiting
Not Applicable
Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis Start of enrollment: 2018 Jul 23
Completed
Phase 4
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is Start of enrollment: 2018 Sep 17
Completed
Phase 2
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis Start of enrollment: 2019 Jan 16
Recruiting
Phase 4
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is Start of enrollment: 2019 Mar 18
Terminated
Phase 2
An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers Start of enrollment: 2019 Jul 31
Completed
Duobrii in Combination With Biologics Start of enrollment: 2019 Oct 14
Recruiting
Phase 4
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis. Start of enrollment: 2020 Apr 06
Recruiting
Phase 4
Taltz in Combination With Enstilar for Psoriasis Start of enrollment: 2020 Apr 28
Recruiting
Phase 4
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Recruiting
Phase 3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial.
Joel M Gelfand, April W Armstrong, Henry W Lim, Steven R Feldman, Sandra M Johnson
JAMA Dermatology. 2024-12-01
Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis in the TARGET-DERM AD Registry.
Michael A Haft, Keith D Knapp, Ami Claxton, Breda Munoz, Julie M Crawford
Current Medical Research and Opinion. 2024-12-01
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials.
Neil J Korman, Richard B Warren, Jerry Bagel, April W Armstrong, Melinda Gooderham
The Journal of Dermatological Treatment. 2024-12-01

Journal Articles

Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the National Psoriasis Foundation
Ronald Prussick, Johann E Gudjonsson, Alice Gottlieb, John Koo, Jerry Bagel, Adam R Ford, Joseph A Markenson, Wilson Liao, Joseph F Merola, Jashin J Wu, JAMA
M2688 The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethosone Dipropionate Improves the Helath-Related Quality of Life in Patients with ...
Jerry Bagel, M.D., et al, Journal of Drugs in Dermatology (JDD), 7/2016
The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethosone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoria...
Jerry Bagel, M.D., et al, Journal of Drugs in Dermatology (JDD), 1/1/2016
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Jerry Bagel, M.D., et al, The New England Journal of Medicine, 10/2015
Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris-A randomized phase II study
Jerry Bagel, M.D., et al, Journal of Dermatological Treatment, 1/1/2015
From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current thera...
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2014
Clinical Study Results of Desoximetasone Spray, 025% In Moderate to Severe Plaque Psoriasis
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2013
Moderate to Severe Plaque Psoriasis with Scalp Involvement: A Randomized, Double-Blind, Placebo-Controlled Study of Etanercept
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2012
Consensus Guidelines for the Management of Plaque Psoriasis
Jerry Bagel, M.D., et al, Archives of Dermatology, 1/1/2012
Adalimumab plus Narrowband Ultraviolet B Light Phototherapy for the Treatment of Moderate to Severe Psoriasis
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2011
Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet: Efficacy and Safety Results from REACH, a Randomized, Placebo-Controlled...
Jerry Bagel, M.D., et al, Archives of Dermatology, 1/1/2011
Adalimumab Plus Narrowband Ultraviolet B Light Phototherapy for the Treatment of Moderate to Severe Psoriasis
Jerry Bagel, M.D., et al, Journal of Drugs in Dermatology, 1/1/2011
A Review of Phototherapy Protocols for Psoriasis Treatment
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2011
Optomizing Topical Therapies for Treating Psoriasis: A Consensus Conference
Jerry Bagel, M.D., et al, Cutis, 1/1/2010
Understanding PML and Risks Associated with Biologic Therapies
Jerry Bagel, M.D., et al, Practical Dermatology, 1/1/2009
Topical Therapies for the Treatment of Plaque Psoriasis
Jerry Bagel, M.D., Cutaneous Medicine for the Practitioner, 1/1/2009
Treatment of intertiginous psoriasis: From the Medical Board of the National Psoriasis Foundation
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2009
Treatment of Effective Therapy: Lead Psoriasis Patients along the Path to Clearance
Jerry Bagel, M.D., et al, Practical Dermatology, 1/1/2009
Treatment of intertriginous psoriasis: From the Medical Board of National Psoriasis Foundation
Jerry Bagel, M.D, Kalb, Korman et al, J Am Acad Dermatology, 1/1/2009
LCD plus NB-UVB reduces Time to Improvement of Psoriasis vs NB-UVB Alone
Jerry Bagel, M.D., et al, Journal of Drugs in Dermatology, 1/1/2009
Topical Psoriasis Therapy: Patients' Experiences, Physicians' Perceptions Don't Always Match
Jerry Bagel, M.D., et al, Practical Dermatology, 1/1/2008
Utilization of Narrow-Band Ultraviolet Light B Therapy and Etanercept for the Treatment of Psoriasis (UNITE): Efficacy, Safety, and Patient-Reported Outcomes
Jerry Bagel, M.D., et al, Journal of Drugs in Dermatology, 1/1/2008
From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2008
Assessment and tracking of long-term alefacept safety
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2007
National Psoriasis Foundation Clinical Consensus on Disease Severity
Jerry Bagel, M.D., et al, Archives of Dermatology, 1/1/2007
Join now to see all

Other

Treatment of Pediatric Psoriasis
Jerry Bagel, M.D., Practical Dermatology
1/1/2010
Clearing Psoriasis: The Role of a Novel 2-Compoound Ointment as First-Line Therapy.
Jerry Bagel, M.D., et al, Skin & Allergy News
1/1/2007
New Perspectives on Methotrexate and Liver Biopsies
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 1, pg. 74-75
1/1/2007
Evaluating the Risks and Benefits of Soriatane
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 2, pg. 82-84
1/1/2007
Exploring Off-Label Use of Biologics for Dermatologic Indications
Jerry Bagel, M.D., Practical Dermatology, Vol.4, No.5, pg.56-58
1/1/2007
Psoriasis Research You and Your Patients Can Take to the Bank
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 5, pg. 56-58
1/1/2007
Guidelines for Use of PUVA and Tips for Success
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 6, pg. 56-57
1/1/2007
Get Familiar with the Biologics Safety Dance
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 7, pg. 17-18
1/1/2007
Building Long-Term Relationships as a Patient Caregiver
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 8, pg. 53-54
1/1/2007
Responding to the Potential Effects of Obesity on Psoriasis
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 9, pg. 46-47
1/1/2007
Effective Strategies To Treat Intertriginous Psoriasis
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 10, pg. 54-58
1/1/2007
Choosing the Safest Psoriasis Treatment for Women of Childbearing Potential
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 11, pg. 50-51
1/1/2007
Be Prepared to Treat Pustular Psoriasis-An Uncommon Variant
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 12, pg. 43
1/1/2007
How and When to Use Cyclosporine in Psoriasis Care
Jerry Bagel, M.D., Practical Dermatology, Vol..3, No. 12. pg. 58-61
1/1/2006
In the Pipeline: Promising Early Data for a New Biologic.
Jerry Bagel, M.D., Practical Dermatology, 3:11 pg. 25-26
1/1/2006
Approaches to Difficult-to-Treat Psoriasis in Specialized Areas.
Jerry Bagel, M.D., Practical Dermatology, 3:10 pg 48-50
1/1/2006
Unlock the Benefits of Phototherapy for Psoriasis
Jerry Bagel, M.D., Practical Dermatology, pg. 41
1/1/2006
A Guide to Introducing Biologic Therapies for Psoriasis into Clinical Practice
Jerry Bagel, M.D., et al, Precept Medical Communications
1/1/2002
Join now to see all

Press Mentions

Dermavant Presents New Patient Satisfaction Data from PSOARING 3 Long Term Extension Trial of Tapinarof in Adults with Plaque Psoriasis at the 2022 Winter Clinical Dermatology ConferenceJanuary 15th, 2022
Dr. Jennifer Soung Named New Psoriasis EditorAugust 16th, 2019
Biologics May Reduce Plaque Buildup in Psoriasis Patients’ ArteriesFebruary 5th, 2019
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow